Literature DB >> 11928071

Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.

S Trenkel1, C Seifarth, H Schobel, E G Hahn, J Hensen.   

Abstract

The ratio of serum aldosterone to plasma renin activity (PRA) has been proposed as sensitive screening method in the diagnosis of primary aldosteronism under random conditions. However, the method for determination of renin activity is hampered by the necessity of ice cooling during storage and transport. The present study was therefore conducted to examine the ratio of serum aldosterone to plasma renin concentration (ARR) and its usefulness in diagnosis of primary aldosteronism under ambulatory conditions and given antihypertensive medication. 146 patients with arterial hypertension who consecutively attended the outpatient clinic were studied prospectively. Patients with secondary hypertension besides primary aldosteronism were not included in the series. 37 normotensive patients served as control. Also, 17 patients with known primary aldosteronism were retrospectively examined. Among the hypertensive group 2 patients with Conn's syndrome were newly detected (1.4%). ARR was 7.92 +/- 6.04 [pg/ml]/[pg/ml] in normotensive controls (range from 2.03 to 26.98), 14.61 +/- 18.50 [pg/ml]/[pg/ml] in patients with essential hypertension (n = 144, range from 0.41 to 115.45) and 155.92 +/- 127.84 [pg/ml]/[pg/ml] in patients with primary aldosteronism (n = 19, range from 6.75 to 515). 17 of the 19 patients with Conn's syndrome had an ARR of more than 50. Under ongoing drug treatment this represents a sensitivity of 89% and a specificity of 96%. Sensitivity decreased to 84% and specificity increased to 100% when a second criteria (aldosterone > or = 200 pg/ml) was included. In summary, ARR using renin concentration is a useful screening parameter for primary aldosteronism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11928071     DOI: 10.1055/s-2002-23491

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  8 in total

1.  [Pareses, myalgias, and massive CK elevation: a severe neurological disorder?].

Authors:  Johannes Steinfurt; Markus C Müller; Anke Seidel; Richard Salm; Andreas Ochs
Journal:  Med Klin (Munich)       Date:  2010-07-30

2.  Mineralocorticoid deficiency in hemorrhagic shock.

Authors:  Nikolai S Tolstoy; Majid Aized; Morgan P McMonagle; Daniel N Holena; Jose L Pascual; Seema S Sonnad; Carrie A Sims
Journal:  J Surg Res       Date:  2012-05-25       Impact factor: 2.192

3.  [80/m-Difficult-to-control arterial hypertension and hypokalemia : Preparation for the medical specialist examination: part 132].

Authors:  B Bader
Journal:  Internist (Berl)       Date:  2022-03-18       Impact factor: 0.743

4.  The effect of vitamin D3 supplementation on markers of cardiovascular health in hyperparathyroid, vitamin D insufficient women: a randomized placebo-controlled trial.

Authors:  Lise Sofie Bislev; Lene Langagergaard Rødbro; Jesper Nørgaard Bech; Erling Bjerregaard Pedersen; Alisa D Kjaergaard; Søren Andreas Ladefoged; Lars Rolighed; Tanja Sikjaer; Lars Rejnmark
Journal:  Endocrine       Date:  2018-07-24       Impact factor: 3.633

5.  Dietary Sodium Modifies Serum Uric Acid Concentrations in Humans.

Authors:  Alwyn S Todd; Robert J Walker; Robert J MacGinley; Jaimon Kelly; Tony R Merriman; Tanya J Major; Richard J Johnson
Journal:  Am J Hypertens       Date:  2017-11-06       Impact factor: 2.689

6.  Active renin mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronism.

Authors:  François Corbin; Pierre Douville; Marcel Lebel
Journal:  Int J Nephrol Renovasc Dis       Date:  2011-07-28

7.  Development and evaluation of an immuno-MALDI (iMALDI) assay for angiotensin I and the diagnosis of secondary hypertension.

Authors:  Alexander G Camenzind; Jessica Grace van der Gugten; Robert Popp; Daniel T Holmes; Christoph H Borchers
Journal:  Clin Proteomics       Date:  2013-12-20       Impact factor: 3.988

8.  Aldosterone/direct renin concentration ratio as a screening test for primary aldosteronism: A meta-analysis.

Authors:  Xiyue Li; Richa Goswami; Shumin Yang; Qifu Li
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-08-17       Impact factor: 1.636

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.